It is a pharma private limited company based in Lucknow, Uttar Pradesh, India, established in 2012.
2012 | Lucknow, Uttar Pradesh, India | ActiveFortuneavere Pharmaceuticals Private Limited, a active private limited company, was established on 27 November 2012 in Lucknow, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74900UP2012PTC053810. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Richa Misra (Director), Kshama Misra (Director), Sanjay Misra (Director). Past directors included Alok Shanker Tewari. It holds ₹0.90 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 4/59, Vivek Khand Gomti Nagar, Lucknow, Uttar Pradesh, 226010.
U74900UP2012PTC053810
053810
27 November 2012
₹0.10 M
₹0.10 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Fortuneavere Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Richa Misra | Director | 27 Nov 2012 | Current |
| Kshama Misra | Director | 01 Jun 2020 | Current |
| Sanjay Misra | Director | 27 Nov 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Feb 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Fortuneavere Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 1.01% increase. The company also saw a substantial fall in profitability, with a 17.5% decrease in profit. The company's net worth dipped by a decrease of 0.78%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Fortuneavere Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹900,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2013 | Uco Bank | ₹0.90 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Fortuneavere Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Fortuneavere Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fortuneavere Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Fortuneavere Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Fortuneavere Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.
The activity Kshama Misra was appointed as a Director was appointed as a Director on 01 Jun 2020 & has been associated with this company since 5 years 6 months . was completed.
Progress on A charge with Uco Bank amounted to Rs. 0.90 M with Charge ID 10444287 was registered on 30 Jun 2013. was documented.
Richa Misra was appointed as a Director was appointed as a Director on 27 Nov 2012 & has been associated with this company since 13 years 4 days . was recorded as a recent event.
Sanjay Misra was appointed as a Director was appointed as a Director on 27 Nov 2012 & has been associated with this company since 13 years 4 days . was recorded as a recent event.
The CIN of Fortuneavere Pharmaceuticals Private Limited is U74900UP2012PTC053810.
Fortuneavere Pharmaceuticals Private Limited is headquartered at 4/59, Vivek Khand Gomti Nagar, Lucknow, Uttar Pradesh, 226010.
Fortuneavere Pharmaceuticals Private Limited was incorporated on 27 November 2012.
The current directors of Fortuneavere Pharmaceuticals Private Limited are
The primary industry of Fortuneavere Pharmaceuticals Private Limited is Trade.
Fortuneavere Pharmaceuticals Private Limited is unlisted.
The authorized capital of Fortuneavere Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Fortuneavere Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX